Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 329 institutions reported holding it in 13F filings for Q2 2026, worth $3.71B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Haemonetics Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Haemonetics Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Madaus Martin D | Director | 2,538 | Jul 28, 2026 | 1 |
| Zane Ellen M | Director | 21,911 | Jul 28, 2026 | 1 |
| Pomeroy Claire | Director | 19,410 | Jul 28, 2026 | 1 |
| Kroll Mark W | Director | 27,295 | Jul 28, 2026 | 2 |
| Johnson Lloyd Emerson | Director | 15,471 | Jul 28, 2026 | 1 |
| Coyle Michael J | Director | 17,932 | Jul 28, 2026 | 1 |
| Bryant Diane M | Director | 9,664 | Jul 28, 2026 | 1 |
| Abernathy Robert E | Director | 27,519 | Jul 28, 2026 | 1 |
| Miller Laurie A. | SVP, Human Resources | 40,987 | Jun 8, 2026 | 2 |
| Maunsell Farris Maryanne | VP, Chief Accounting Officer | 6,242 | Jun 8, 2026 | 2 |
| DArecca James | EVP, Chief Financial Officer | 54,444 | May 19, 2026 | 2 |
| Simon, Christopher | President & CEO | 444,704 | May 19, 2026 | 1 |
| Basil Michelle L | EVP and General Counsel | 68,829 | May 19, 2026 | 1 |
| Galvin Roy | EVP, Chief Commercial Officer | 39,882 | May 19, 2026 | 2 |
| Chan Frank | EVP, Chief Operating Officer | 32,936 | May 19, 2026 | 1 |
| Dockendorff Charles J | Director | 7,126 | Jul 25, 2025 | 0 |
| Strong Stewart W | President, Global Hospital | 18,196 | Jul 29, 2024 | 0 |
| Lingamneni Anila | EVP, Chief Technology Officer | 21,331 | Jul 15, 2024 | 0 |
| Llorens Josep | EVP, Global Manufacturing | 30,940 | May 29, 2024 | 0 |
| Burzik Catherine M | Director | 19,545 | Aug 8, 2022 | 0 |
| Goldstein Dan | VP, Corporate Controller | 4,447 | Jun 15, 2022 | 0 |
| Burke William P. Mr. | EVP, Chief Financial Officer | 30,291 | Aug 25, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Kroll Mark WDirector | PPurchase | +1.40K | $70.56 | +$98.8K | +6.0%24.8K after |